Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2006-10-22 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第五届董事会第二十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the 21st meeting of the 5th Board of Directors of Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It includes the approval of the company's 2006 Q3 report and a change in the company's securities affairs representative. The document is short (657 characters) and primarily reports on board decisions, including management changes. It does not contain the full quarterly report or detailed financial data, but rather announces the approval of the report and a management change. Therefore, it fits best under Board/Management Information (MANG) due to the announcement of a change in the company's securities affairs representative, which is a senior management role. The mention of the quarterly report approval is incidental and does not make this document an Interim/Quarterly Report (IR).
2006-10-22 Chinese
股权分置方案实施公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the implementation of a share reform plan (股权分置改革方案实施公告) by Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It details the share reform scheme, including share compensation, cash payments, share registration dates, listing dates, and changes in shareholding structure. The document includes specific dates, shareholder meeting results, and procedural details about the share reform implementation. It is not a full financial report, earnings release, or management discussion, but rather a formal announcement of a corporate action related to capital structure and share reform. This fits best under Capital/Financing Update (CAP) as it concerns changes in capital structure and shareholding arrangements due to the share reform plan.
2006-07-12 Chinese
马 应 龙2006年中期报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2006 年中期报告' which translates to '2006 Interim Report' for Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It contains detailed financial data including balance sheets, profit and loss data, management discussion and analysis, shareholder information, and other comprehensive financial and operational details for the first half of 2006. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of unaudited financial statements and management discussion confirms it is an interim or quarterly report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2006
2006-07-12 Chinese
马 应 龙2006年中期报告摘要
Interim / Quarterly Report Classification · 100% confidence The document is titled as a '2006 Mid-Year Report Summary' (中期报告摘要) for Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It contains detailed financial data for the first half of 2006, including balance sheet items, profit and loss statements, cash flow, segment information, shareholder information, management discussion and analysis, and notes on fundraising usage. The report explicitly states it is an unaudited interim financial report for the period January to June 2006. The length of the document (9233 characters) and the presence of substantive financial data and analysis confirm it is a comprehensive interim report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2006
2006-07-12 Chinese
2005年度分红派息实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of dividend distribution for the fiscal year 2005 by Wuhan Mayinglong Pharmaceutical Group Co., Ltd. It details the dividend amount per share, tax information, record date, ex-dividend date, and payment date. It also references the approval of the dividend plan at the 2005 Annual General Meeting and provides instructions for shareholders on how to receive dividends. The document does not contain financial statements or detailed financial performance data but focuses solely on dividend payment details. Therefore, it fits the category of a Notice of Dividend Amount (DIV). The document length is short (1609 characters), and it is not a report publication announcement or a regulatory filing. Hence, the classification is DIV with high confidence.
2006-07-06 Chinese
股权分置改革相关股东会议表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the voting results from a shareholders' meeting related to the company's equity reform plan. It details the meeting date, voting methods, attendance, vote counts, and legal opinions confirming the validity of the meeting and voting process. There is no financial data or report content, only the official results of the shareholder vote. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is under 5,000 characters and is clearly a voting result announcement, not a full report or presentation.
2006-07-04 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.